Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.

Torrico F, Gascon J, Ortiz L, Alonso-Vega C, Pinazo MJ, Schijman A, Almeida IC, Alves F, Strub-Wourgaft N, Ribeiro I. Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial. Lancet Infect Dis. 2018 04; 18(4):419-430.

View in: PubMed

subject areas

Administration, Oral
Adolescent
Adult
Bolivia
Chagas Disease
Double-Blind Method
Female
Humans
Incidence
Male
Middle Aged
Nitroimidazoles
Placebos
Polymerase Chain Reaction
Prospective Studies
Thiazoles
Treatment Outcome
Triazoles
Trypanocidal Agents
Trypanosoma cruzi
Young Adult

authors with profiles

Igor C. Almeida

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support